Publicaciones en colaboración con investigadores/as de Cambridgeshire and Peterborough NHS Foundation Trust (29)

2024

  1. Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part I

    Journal of Psychopharmacology

  2. Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part II

    Journal of Psychopharmacology

  3. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS

    Early Intervention in Psychiatry, Vol. 18, Núm. 4, pp. 255-272

2023

  1. Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: Results from the EU-GEI case-control study

    Psychological Medicine, Vol. 53, Núm. 15, pp. 7375-7384

  2. Common practical questions – and answers – at the British Association for Psychopharmacology child and adolescent psychopharmacology course

    Journal of Psychopharmacology, Vol. 37, Núm. 2, pp. 119-134

  3. Development and Validation of Predictive Model for a Diagnosis of First Episode Psychosis Using the Multinational EU-GEI Case-control Study and Modern Statistical Learning Methods

    Schizophrenia Bulletin Open, Vol. 4, Núm. 1

  4. Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study

    Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280

  5. Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study

    Molecular Psychiatry, Vol. 28, Núm. 5, pp. 2095-2106

  6. The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study

    Psychological medicine, Vol. 53, Núm. 15, pp. 7418-7427

  7. The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study

    Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580

  8. Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; The EU-GEI study

    Psychological Medicine, Vol. 53, Núm. 8, pp. 3396-3405

2022

  1. Authors' reply to 'on the existence of a linguistic distance in schizophrenia'

    Psychological Medicine

  2. Childhood Maltreatment, Educational Attainment, and IQ: Findings from a Multicentric Case-control Study of First-episode Psychosis (EU-GEI)

    Schizophrenia Bulletin, Vol. 48, Núm. 3, pp. 575-589

  3. Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case-Control Study

    Schizophrenia bulletin, Vol. 48, Núm. 5, pp. 1104-1114

  4. Genetic and psychosocial stressors have independent effects on the level of subclinical psychosis: findings from the multinational EU-GEI study

    Epidemiology and psychiatric sciences, Vol. 31, pp. e68

  5. Global population attributable fraction of potentially modifiable risk factors for mental disorders: a meta-umbrella systematic review

    Molecular Psychiatry, Vol. 27, Núm. 8, pp. 3510-3519

  6. Migration history and risk of psychosis: Results from the multinational EU-GEI study

    Psychological Medicine, Vol. 52, Núm. 14, pp. 2972-2984

  7. The effect of early life events on glucose levels in first-episode psychosis

    Frontiers in Endocrinology, Vol. 13

2021

  1. Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls

    Psychological Medicine, Vol. 51, Núm. 12, pp. 2074-2082

  2. Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: The EU-GEI case-control study

    Psychological Medicine, Vol. 51, Núm. 8, pp. 1329-1337